Optometrists’ Role in Retinal Care in the Anti-VEGF Era

Clinical Report: Optometrists’ Role in Retinal Care in the Anti-VEGF Era

Overview

Optometrists have transitioned from referral gatekeepers to active partners in managing retinal conditions, particularly in the context of anti-VEGF therapies. Key findings indicate that a significant percentage of patients with neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) can maintain or improve vision with appropriate monitoring and treatment, as outlined by Dr. Roya Attar.

Background

The management of retinal diseases has evolved significantly with the introduction of anti-VEGF therapies, which have become the standard of care. Understanding the role of optometrists in this landscape is crucial as they play a vital part in the longitudinal care and monitoring of patients with conditions like nAMD, DME, and RVO, as emphasized by Dr. Attar.

Data Highlights

Condition	Vision Maintenance	Vision Improvement
nAMD	90%	30-40%
DME	40-60%	30-40% complete resolution
RVO	50-70%	60-80% edema resolution

Key Findings

Optometrists are now longitudinal care partners in retinal disease management, as stated by Dr. Attar.
90% of nAMD patients maintain vision with anti-VEGF treatment.
40-60% of DME patients experience vision improvement.
Assessment of retinal conditions should be longitudinal, considering both anatomical and functional responses.
Persistent intraretinal fluid (IRF) is a critical indicator of potential visual outcomes.

Clinical Implications

Optometrists should utilize OCT, best-corrected visual acuity (BCVA), and functional tests to monitor patients effectively, as recommended by Dr. Attar. Recognizing signs of instability, such as new IRF or significant changes in CST, is essential for timely communication with retina specialists.

Conclusion

The evolving role of optometrists in retinal care highlights the importance of collaborative management strategies in the anti-VEGF era, as discussed by Dr. Attar.